Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-70
SponsorUniversity of Arkansas

About this trial

To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals

Eligibility criteria

Qualifiers

Males and females ages 50-70 years.

Body mass index between 25-45 kg/m2

Capable of providing informed consent.

COVID-19 negative and/or asymptomatic.

Disqualifiers

Subject who does not/will not eat dairy protein sources.

Subjects taking exogenous insulin injections or GLP /GIP injections or other appetite suppressants.

Unwilling to keep a detailed 7 day food journal on two occasions

Unwilling to wear a CGM for 7 days on two occasions and share the data with the research team.

Trial design

Treatments tested in this trial

  • Whey Protein Isolate Crossover
  • Placebo

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Arkansas

Lead sponsor

National Dairy Council

Collaborator